Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis다발성 경화증 환자에서 리툭시맙 투여 후 SARS-CoV-2 재활성화Case Reports Published on 2021-07-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] SARS, 바이오마커, 진단, 치료기술, [키워드] Admission alveolar anti-CD20 anti-CD20 treatment Antibody testing conditions COVID-19 highly active Hypogammaglobulinemia infected with SARS-CoV-2 infusion IVIG Multiple multiple sclerosis Nasopharyngeal swab nasopharyngeal swabs other conditions Reactivation receiving reduce Reinfection reported required respiratory respiratory symptom respiratory symptoms risk rituximab SARS-CoV-2 SARS-COV-2 infection sclerosis Treatment [DOI] 10.1016/j.msard.2021.102922 PMC 바로가기 [Article Type] Case Reports
Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusion클리닉 기반 면역 글로불린 주입에서 가정 기반 면역 글로불린 주입으로 전환하여 COVID-19 노출 위험 완화Article Published on 2021-06-072022-09-12 Journal: American journal of health-system pharmacy : AJHP [Category] MERS, SARS, 진단, [키워드] Administered administration Analysis candidate clinic collected Complication concern conducted coronavirus disease COVID-19 criteria decrease demonstrated dose effective Efficacy Follow-up had no Hypogammaglobulinemia identify immune Immunosuppressed immunosuppressed patient immunosuppressed population increase in intravenous intravenous immune globulin Medicare outcome pandemic Part Patient Patient care Patient satisfaction positive questionnaire receiving reduction in reported resulting risk of COVID-19 risk of infections Safe shown study period subcutaneous immune globulin. tested therapy transition Transmission virus was performed [DOI] 10.1093/ajhp/zxab072 PMC 바로가기 [Article Type] Article
COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review체액성 면역 결핍증에서 코로나19 중화 항체 기반 요법: 내러티브 검토Review Published on 2021-06-012022-09-12 Journal: Transfusion and apheresis science : official journ [Category] MERS, SARS, 신약개발, 진단, [키워드] acute respiratory syndrome agammaglobulinemia Alymphocytosis anti-viral agents antibody-based therapy benefit cancers category caused Cell clinician congenital convalescent plasma coronavirus coronavirus disease COVID-19 COVID-19 patient deficiencies develop effective effort Evidence first positive Health hematologic humoral Hypogammaglobulinemia immune Immune deficiencies Immunotherapy Neutralizing Neutralizing antibodies organ outbreak Passive Patient patients recipient recovered patient Research SARS-CoV-2 severe COVID-19 patients therapy transplantation transplants treatment protocols [DOI] 10.1016/j.transci.2021.103071 PMC 바로가기 [Article Type] Review
Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma회복기 혈장으로 치료한 낮은 감마글로불린 수치 및 재발된 covid-19 감염과 관련된 리툭시맙을 가진 2명의 환자Case Reports Published on 2021-06-012022-09-12 Journal: Transfusion and apheresis science : official journ [Category] MERS, 진단, [키워드] absence antibody chemo-immunotherapy Clinical improvement convalescent plasma COVID-19 CP infusion disease haematological malignancy Hypogammaglobulinemia Infection limitation lymphoma mandatory Neurological complications neutralising antibody new treatment strategy off-label Patient PCR positive risk rituximab SARS-CoV-2 Symptom therapeutic options therapy treated Two patient Viral load virus [DOI] 10.1016/j.transci.2021.103104 PMC 바로가기 [Article Type] Case Reports
COVID-19 Virus Infection in Three Patients With HypogammaglobulinemiaInfectious Disease Published on 2021-05-262022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome beta coronavirus Cancer cancer patient caused cellular immune function Chemotherapy Clinical outcome coronavirus COVID 19 COVID-19 COVID-19 outbreak humoral Hypogammaglobulinemia Immunocompromised patients include individuals without cancer Infection Intravenous immunoglobulin Intravenous immunoglobulin (IVIG) lymphoma malignancy mantle cell mantle cell lymphoma Multiple myeloma Patient respiratory infection SARS-CoV-2 Support susceptible treatment strategy viral shedding [DOI] 10.7759/cureus.15256 PMC 바로가기 [Article Type] Infectious Disease
Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients중환자 코로나바이러스 질환 2019 환자에서 뚜렷한 면역표현형 식별Article Published on 2021-05-012022-08-31 Journal: Chest [Category] MERS, SARS, 바이오마커, [키워드] Activation Acute respiratory failure cause CD4+ CD8+ clinical trial Cluster Clustering complement Complement activation conducted coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient Critical Critical care Critically ill critically ill COVID-19 patients cytokine cytokine level cytokine release elevated eligibility endothelial enrolled evaluated exaggerated inflammatory response exhibiting favor feature France group heterogeneous Hierarchical hierarchical clustering Hypogammaglobulinemia ICU ICU admission identification IL-1β IL-6 IL-8 Ill immunodeficiency immunologically immunology immunophenotype Infection Inflammation inflammatory reaction lung damage marker mediators moderate multi-organ dysfunction Necrosis outcomes Patient patient identification patients phenotype predominant principal components principal components analysis Profiling Prospective Study respiratory Respiratory failure response to therapies SARS-CoV-2 SARS-COV-2 infection SC5b-9 Severe acute respiratory syndrome severe acute respiratory syndrome-coronavirus-2 severe COVID-19 severity shown single-center targeted therapy therapeutic therapy Trajectories tumor necrosis tumor necrosis factor tumor necrosis factor-alpha Variability variable [DOI] 10.1016/j.chest.2020.11.049 PMC 바로가기 [Article Type] Article
COVID-19, HHV6 and MOG antibody: A perfect stormCOVID-19, HHV6 및 MOG 항체: 완벽한 폭풍우Case Reports Published on 2021-04-152022-09-11 Journal: Journal of neuroimmunology [Category] MERS, SARS, 진단, 치료제, [키워드] antibody Central nervous system checked Coinfection Complete Corticosteroids COVID-19 COVID19 Demyelination gancyclovir HHV6 High dose Hypogammaglobulinemia immunodeficiency increasingly Infection knowledge lymphopenia MOG Myelitis neurological Neurological complication neurological manifestation neurological manifestations opportunistic infection opportunistic Infections Patient patients with SARS-CoV-2 plasma plasma exchange SARS-CoV-2 tested transverse myelitis Trigger Viral viral infection [DOI] 10.1016/j.jneuroim.2021.577521 PMC 바로가기 [Article Type] Case Reports
Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature reviewCase Report Published on 2021-04-082024-09-02 Journal: Annals of Clinical Microbiology and Antimicrobials [Category] 대상포진, [키워드] Helicobacter canis Hypogammaglobulinemia Immunocompromised rheumatoid arthritis Tofacitinib Treatment zoonosis [DOI] 10.1186/s12941-021-00426-x PMC 바로가기 [Article Type] Case Report
Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort studyObservational Research Published on 2021-04-032024-09-04 Journal: Rheumatology International [Category] 대상포진, [키워드] Autoimmune disease Hypogammaglobulinemia Infection rituximab vaccination [DOI] 10.1007/s00296-021-04847-x PMC 바로가기 [Article Type] Observational Research
Can We Restore Immunocompetence in CLL?Article Published on 2021-03-302024-09-04 Journal: Hematology/oncology clinics of North America [Category] 대상포진, [키워드] Hypogammaglobulinemia Infection leukemia second primary malignancy T cell Vaccine [DOI] 10.1016/j.hoc.2021.03.010 PMC 바로가기 [Article Type] Article